CAS: 844873-47-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Evodenoson REF: 54-BUP08055CAS: 844873-47-8 | ≥98% | 344.00 €~7,264.00 € | Fri 03 Oct 25 |
 | ATL-313-d4 REF: TR-A790502CAS: 844873-47-8 | - - - | 14,830.00 € | Wed 12 Nov 25 |
 | Evodenoson REF: TM-T31731CAS: 844873-47-8 | 99.74% - 99.84% | 238.00 €~3,535.00 € | Fri 28 Nov 25 |
Ref: 54-BUP08055
| 5mg | 823.00 € | ||
| 10mg | 1,146.00 € | ||
| 25mg | 2,203.00 € | ||
| 50mg | 2,964.00 € | ||
| 100mg | 4,481.00 € | ||
| 500mg | 7,264.00 € |
Estimated delivery in United States, on Friday 3 Oct 2025
ATL-313-d4
Controlled ProductCAS:844873-47-8
Applications Isotope labelled analogue of ATL-313, an adenosine A2A receptor agonists used as a potential …
Formula:
C23D4H25N7O6
Color and Shape:
Neat
Molecular weight:
503.544
Ref: TR-A790502
| 25mg | 14,830.00 € |
Estimated delivery in United States, on Wednesday 12 Nov 2025
Evodenoson
CAS:844873-47-8
Evodenoson (ATL313), a potent A2aR agonist, treats eye diseases, tumors, and immune disorders; potential for …
Formula:
C23H29N7O6
Purity:
99.74% - 99.84%
Color and Shape:
Solid
Molecular weight:
499.52
Ref: TM-T31731
| 1mg | 238.00 € | ||
| 5mg | 598.00 € | ||
| 10mg | 903.00 € | ||
| 25mg | 1,736.00 € | ||
| 50mg | 2,337.00 € | ||
| 100mg | 3,535.00 € |
Estimated delivery in United States, on Friday 28 Nov 2025
